Cancer Care Ontario | Action Cancer Ontario

Les programmes provinciaux de remboursement des médicaments (PPRM) permettent de financer les médicaments contre le cancer et les services connexes....

Provincial Drug Reimbursement Programs

The Provincial Drug Reimbursement Programs (PDRP) administers funding programs for cancer drugs and services. These programs help patients access...

Guidelines and Advice

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Updated

Mar 2025

Guidelines and Advice

An Endorsement of the 2021 Guideline on the Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update

Status: In-Review
ID: GL END 3-23
Version: N/A

Oct 2021

Drug

pomalidomide

Other Name(s): Pomalyst®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Dec 1969

Guidelines and Advice

Active Surveillance for the Management of Localized Prostate Cancer

Status: In-Review
ID: 17-9

Dec 1969

Regimen

ATEZBEVA(MNT)

Cancer Type:

Lung,

Non-Small Cell

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Drugs Used:

atezolizumab (Unfunded),

bevacizumab (Unfunded)

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

PGLDX

PGLDX

PGLDX

Programme ontarien de dépistage du cancer du poumon

Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer

Programmes provinciaux de remboursement des médicaments

Provincial Drug Reimbursement Programs

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

An Endorsement of the 2021 Guideline on the Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update

pomalidomide

Active Surveillance for the Management of Localized Prostate Cancer

ATEZBEVA(MNT)

Pages